Search

Search Constraints

You searched for: Author/Creator Fowler, Christopher

Search Results

2. [O1–06–04]: CSF P‐TAU IS CORRELATED WITH TAU PET, WHILE Aβ PET CORRELATES WITH Aβ1–42 AND THE T‐TAU/Aβ1–42 RATIO. (1st July 2017)

3. [P1–416]: CSF TOTAL TAU AS A BIOMARKER FOR NEURONAL INJURY IN ALZHEIMER's DISEASE: ALIGNING RATES OF CSF CHANGE WITH RATES OF HIPPOCAMPAL AND CORTICAL GRAY MATTER ATROPHY. (1st July 2017)

4. A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8‐OH quinoline in Alzheimer's disease: The PBT2‐204 IMAGINE study. Issue 4 (9th November 2017)

6. Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology. Issue 1 (December 2015)

7. Alzheimer's disease specific MRI brain regions are differentially associated with accelerated decline as defined using sigmoidal cognitive turning point methodology in amyloid‐positive AIBL participants. (20th December 2022)

8. AlzoSure® Predict, a simple minimally‐invasive blood test to predict the early onset of Alzheimer's disease before the manifestation of clinical symptoms. (20th December 2022)